Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-13 4:40 pm Sale | 13G | UNITED THERAPEUTICS CORP UTHR | INTEGRATED CORE STRATEGIES (US) LLC | 1,212,923 2.8% | -1,027,853 (-45.87%) | View |
| 2020-02-13 2:08 pm Purchase | 13G | UNITED THERAPEUTICS CORP UTHR | RENAISSANCE TECHNOLOGIES LLC | 3,544,433 8.08% | 1,347,655 (+61.35%) | View |
| 2020-02-12 07:57 am Purchase | 13G | UNITED THERAPEUTICS CORP UTHR | VANGUARD GROUP INC | 4,052,047 9.23% | 144,768 (+3.71%) | View |
| 2020-02-07 4:30 pm Purchase | 13G | TRANSMEDICS GROUP INC TMDX | UNITED THERAPEUTICS Corp UTHR | 1,458,413 6.89% | 1,458,413 (New Position) | View |
| 2020-02-07 11:32 am Sale | 13G | UNITED THERAPEUTICS CORP UTHR | FMR LLC | 2,383,549 5.431% | -486,975 (-16.96%) | View |
| 2020-02-04 12:30 pm Sale | 13G | UNITED THERAPEUTICS CORP UTHR | BlackRock Inc. BLK | 4,641,085 10.6% | -300,914 (-6.09%) | View |
| 2019-08-12 4:53 pm Purchase | 13G | UNITED THERAPEUTICS CORP UTHR | INTEGRATED CORE STRATEGIES (US) LLC | 2,240,776 5.1% | 2,240,776 (New Position) | View |